Physician profile
Chelsea Viola
NPI 1245658681
$9,650.36
in general payments reported to CMS, 2019-2025
22 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,913 · 2020: $2,078 · 2021: $2,705 · 2022: $2,202 · 2023: $505 · 2024: $106 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $753.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,886.92 | 2019-2024 | Anchorage, Prostep |
| Orthofix Medical, INC. | $1,986.98 | 2021-2024 | Physio-Stim, Accelstim |
| Arthrex, INC. | $1,520.00 | 2021 | |
| Gotham Surgical Solutions & Devices, INC. | $915.82 | 2020 | |
| Organogenesis INC. | $702.76 | 2019-2025 | Cygnus Dual |
| Smith+Nephew, INC. | $503.86 | 2020-2024 | Stravix, Grafix Pl, Grafix |
| Zimmer Biomet Holdings, INC. | $398.41 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $142.01 | 2020 | |
| Acera Surgical, INC. | $113.04 | 2022 | |
| Integra Lifesciences Corporation | $80.06 | 2020 | |
| Davol INC. | $79.45 | 2020-2021 | |
| Bioventus LLC | $69.88 | 2019-2021 | |
| Misonix INC | $66.44 | 2021 | |
| Biocomposites INC | $35.43 | 2019 | |
| Ossio INC | $35.08 | 2023 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $21.34 | 2023 | Blastx, Xperience, Surgx |
| Depuy Synthes Sales INC. | $20.26 | 2025 | Healix Knotless Peek, Dynacord |
| Medtronic, INC. | $17.03 | 2025 | Intellis Adaptivestim |
| Convatec INC. | $15.02 | 2019 | |
| Trevena, INC. | $14.58 | 2021 | |
| Acell, INC. | $14.02 | 2020 | |
| Kci USA, INC. | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsea Viola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.